share_log

HC Wainwright & Co. Reiterates Buy on Onconova Therapeutics, Maintains $11 Price Target

HC Wainwright & Co. Reiterates Buy on Onconova Therapeutics, Maintains $11 Price Target

HC Wainwright & Co.重申买入Onconova Therapeutics,维持11美元的目标股价
Benzinga ·  2023/10/12 10:29

HC Wainwright & Co. analyst Joseph Pantginis reiterates Onconova Therapeutics (NASDAQ:ONTX) with a Buy and maintains $11 price target.

HC Wainwright&Co.分析师约瑟夫·潘特吉尼斯重申安科诺瓦治疗公司(纳斯达克:ONTX)的买入,并维持11美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发